172 related articles for article (PubMed ID: 33530088)
1. Stereotactic Ablative Radiotherapy for the Management of Liver Metastases from Neuroendocrine Neoplasms: A Preliminary Study.
Hudson JM; Chung HT; Chu W; Taggar A; Davis LE; Hallet J; Law CHL; Singh S; Myrehaug S
Neuroendocrinology; 2022; 112(2):153-160. PubMed ID: 33530088
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
[TBL] [Abstract][Full Text] [Related]
3. Dose-effect relationships in neuroendocrine tumour liver metastases treated with [
Ramdhani K; Beijer-Verduin J; Ebbers SC; van Rooij R; Smits MLJ; Bruijnen RCG; de Jong HWAM; Lam MGEH; Braat AJAT
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2114-2123. PubMed ID: 38369678
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma.
Guarneri A; Franco P; Romagnoli R; Trino E; Mirabella S; Molinaro L; Rizza G; Filippi AR; Carucci P; Salizzoni M; Ricardi U
Radiol Med; 2016 Nov; 121(11):873-881. PubMed ID: 27447803
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.
Comito T; Cozzi L; Clerici E; Campisi MC; Liardo RL; Navarria P; Ascolese A; Tozzi A; Iftode C; De Rose F; Villa E; Personeni N; Rimassa L; Santoro A; Fogliata A; Mancosu P; Tomatis S; Scorsetti M
BMC Cancer; 2014 Aug; 14():619. PubMed ID: 25163798
[TBL] [Abstract][Full Text] [Related]
7. Active breathing control guided stereotactic body ablative radiotherapy for management of liver metastases from colorectal cancer.
Gamsiz H; Sager O; Uysal B; Dincoglan F; Demiral S; Colak O; Ozcan F; Dirican B; Beyzadeoglu M
Acta Gastroenterol Belg; 2022; 85(3):469-475. PubMed ID: 35770280
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.
Folkert MR; Meyer JJ; Aguilera TA; Yokoo T; Sanford NN; Rule WG; Mansour J; Yopp A; Polanco P; Hannan R; Nedzi LA; Timmerman RD
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1387-1395. PubMed ID: 33340601
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Ablative Radiation Therapy for Large (≥5 cm) Non-small Cell Lung Carcinoma.
McDermott RL; Mihai A; Dunne M; Keys M; O'Sullivan S; Thirion P; ElBeltagi N; Armstrong JG
Clin Oncol (R Coll Radiol); 2021 May; 33(5):292-299. PubMed ID: 33309479
[TBL] [Abstract][Full Text] [Related]
10. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
[TBL] [Abstract][Full Text] [Related]
11. Initial Experience with CT-Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases.
Schippers AC; Collettini F; Steffen IG; Wieners G; Denecke T; Pavel M; Wust P; Gebauer B
J Vasc Interv Radiol; 2017 May; 28(5):672-682. PubMed ID: 27645463
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases.
McDermott RL; Dunne EM; Zhao Y; Bergman A; Liu MC; Schellenberg D; Ma RM
Clin Colorectal Cancer; 2023 Mar; 22(1):120-128. PubMed ID: 36526537
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of everolimus and radiation for neuroendocrine liver metastases.
Myrehaug S; Chan DL; Rodriguez-Freixinos V; Chung H; Hallet J; Law C; Patel C; Milot L; Hudson J; Chen H; Singh S
Endocr Relat Cancer; 2021 Jun; 28(8):541-548. PubMed ID: 34018490
[TBL] [Abstract][Full Text] [Related]
14. A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases.
Meyer JJ; Foster RD; Lev-Cohain N; Yokoo T; Dong Y; Schwarz RE; Rule W; Tian J; Xie Y; Hannan R; Nedzi L; Solberg T; Timmerman R
Ann Surg Oncol; 2016 Jan; 23(1):218-24. PubMed ID: 25963478
[TBL] [Abstract][Full Text] [Related]
15. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.
Takeda A; Sanuki N; Eriguchi T; Kobayashi T; Iwabutchi S; Matsunaga K; Mizuno T; Yashiro K; Nisimura S; Kunieda E
J Gastroenterol Hepatol; 2014 Feb; 29(2):372-9. PubMed ID: 23927053
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors.
Moding EJ; Liang R; Lartey FM; Maxim PG; Sung A; Diehn M; Loo BW; Gensheimer MF
Clin Lung Cancer; 2019 Nov; 20(6):461-468.e2. PubMed ID: 31377143
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors: A Retrospective Case Series Evaluating Clinical Outcomes, Toxicity, and Technical Considerations.
Correa RJM; Rodrigues GB; Chen H; Warner A; Ahmad B; Louie AV
Am J Clin Oncol; 2018 Jun; 41(6):568-575. PubMed ID: 27635623
[TBL] [Abstract][Full Text] [Related]
20. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
